KI-Beratung Beta

Produktbild: Imatinib plasma concentrations variability in oncologic patients
- 15%

Imatinib plasma concentrations variability in oncologic patients Is imatinib a candidate drug for a therapeutic drug monitoring program?

15% sparen

66,99 € UVP 79,00 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity. Moreover, resistance or escape from disease control are occurring....

Beschreibung

The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity. Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.08.2010

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

248

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.08.2010

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

248

Maße (L/B/H)

22/15/1,6 cm

Gewicht

387 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-8383-8511-2

Herstelleradresse


Email: info@bod.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Imatinib plasma concentrations variability in oncologic patients